Cargando…
The New T Cell Subset Opens a New Realm for Tumor Immunotherapy
Immunotherapy with immune checkpoint inhibitors had achieved great success. However, only a subset of patients responds positively to these therapies. The latest study published on Nature by Chou and colleagues found a new T cell subset from tumor-infiltrating T cells which lack PD-1 on the cell sur...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666835/ https://www.ncbi.nlm.nih.gov/pubmed/36377088 http://dx.doi.org/10.1177/09636897221138037 |